Siller-Matula, J M <br/><br/>
Phenotyping vs. genotyping for prediction of clopidogrel efficacy and safety: the PEGASUS-PCI study.  [electronic resource] 

 -  Journal of thrombosis and haemostasis : JTH  Apr 2012 
 - 529-42 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-7836 
<br/><br/><label>Standard No.: </label>10.1111/j.1538-7836.2012.04639.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Angioplasty, Balloon, Coronary--adverse effects<br/>Aryl Hydrocarbon Hydroxylases--genetics<br/>Austria<br/>Blood Platelets--drug effects<br/>Cardiovascular Diseases--blood<br/>Cell Adhesion Molecules--blood<br/>Chi-Square Distribution<br/>Clopidogrel<br/>Coronary Artery Disease--blood<br/>Cytochrome P-450 CYP2C19<br/>Female<br/>Gene Frequency<br/>Genotype<br/>Hemorrhage--chemically induced<br/>Humans<br/>Kaplan-Meier Estimate<br/>Logistic Models<br/>Male<br/>Microfilament Proteins--blood<br/>Middle Aged<br/>Multivariate Analysis<br/>Pharmacogenetics<br/>Phenotype<br/>Phosphoproteins--blood<br/>Phosphorylation<br/>Platelet Aggregation--drug effects<br/>Platelet Aggregation Inhibitors--adverse effects<br/>Platelet Function Tests<br/>Polymorphism, Genetic<br/>Predictive Value of Tests<br/>Prospective Studies<br/>Risk Assessment<br/>Risk Factors<br/>Sensitivity and Specificity<br/>Thrombosis--blood<br/>Ticlopidine--adverse effects<br/>Time Factors<br/>Treatment Outcome<br/>Vasodilator-Stimulated Phosphoprotein